ArticleEuropean radiology2026
The role of cardiac CT with late iodine enhancement in patients with acute cardiac symptoms and troponin elevation in the era of high-sensitivity assays.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesDiagnostic workup of patients with acute cardiac symptoms, troponin elevation, and no acute myocardial infarction (AMI) criteria is challenging. Cardiac CT angiography (CCTA) rules out obstructive coronary artery disease (CAD). Adding late iodine enhancement and extracellular volume fraction (CCTA + LIE/ECV) provides insights into myocardial injury. However, the impact on working diagnosis, agreement with discharge diagnosis, and mid-term safety of implementing CCTA + LIE/ECV in the emergency department remains uncertain. MATERIALS AND
methodsProspective study on consecutive patients presenting, from June 2018 to February 2025, with acute chest pain or equivalents, elevated troponin, and no AMI diagnosis, excluding previously revascularized patients. Patients underwent CCTA to rule out obstructive CAD (≥ 50% stenosis). CCTA-negative patients underwent myocardial tissue characterization with LIE; if negative, ECV was quantified. PRIMARY ENDPOINT: modification of working diagnosis by CT. Secondary endpoints: agreement between CT and discharge diagnoses after standard-of-care assessment; mid-term major adverse cardiovascular events (MACEs) in CT-negative patients.
resultsAmong 191 patients (age 70 [55-79] years; 53% men), CCTA identified obstructive CAD in 76/191 (40%). LIE/ECV were positive in 58/106 (55%) of CCTA-negative cases, revealing myocarditis in 32/106 (30%), AMI with non-obstructive CAD in 8/106 (8%), Takotsubo in 14/106 (13%), amyloidosis in 3/106 (3%), and dilated cardiomyopathy in 1/106 (1%). CT modified the working diagnosis in 91/191 (48%) patients. Agreement between CT and discharge diagnosis was 0.94 (95% CI 0.89-0.97). In patients with negative CCTA + LIE/ECV, no MACEs occurred after 24 [interquartile range, 19-29] months.
conclusionIn patients with acute symptoms, elevated troponin, and no AMI, a protocol combining CCTA + LIE/ECV enables etiologic assessment of coronary and myocardial conditions, refines working diagnosis, and entails a favorable prognosis when negative. KEY POINTS: Question Patients with acute cardiac symptoms, troponin elevation, and no evidence of acute myocardial infarction represent a diagnostic challenge: cardiac CT with late iodine enhancement may have diagnostic and prognostic implications. Findings CT angiography with late iodine enhancement provided a diagnosis in 75% of patients and modified the working diagnosis in 48%. In the 25% CT-negative patients, no adverse events occurred at mid-term follow-up. Clinical relevance A CT protocol including coronary artery evaluation and myocardial tissue characterization may provide a rapid etiological diagnosis in patients with acute symptoms and troponin elevation, potentially supporting earlier clinical decision-making and reducing the need for additional downstream testing.
Indexed as
Identifiers
42878809What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.